| Literature DB >> 34242124 |
Tamar A Smith-Norowitz1, Jonathan I Silverberg2, Esther M Norowitz1, Stephan Kohlhoff1, Margaret R Hammerschlag1.
Abstract
The Coronavirus disease-2019 (COVID-19) pandemic led to the development of several candidate vaccines. However, current research suggests that the potential of successful vaccines is tempered by vaccine skepticism or hesitancy. If vaccine efficacy is 80%, then the herd immunity required from vaccination is about 75-90%. The aim of the current study was to study factors impacting COVID-19 vaccine hesitancy in a representative sample of adults (age≥18 years) in a COVID-19 hotspotAbbreviations: COVID-19: coronavirus disease-19.Entities:
Keywords: COVID-19; COVID-19 vaccine; New York; seasonal influenza vaccine; vaccine hesitancy
Mesh:
Substances:
Year: 2021 PMID: 34242124 PMCID: PMC8828105 DOI: 10.1080/21645515.2021.1948786
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 4.526